The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Column Group Llc since 2021.
This trader's CIK number is 1833486.
At the time of last reporting, Column Group Llc was the 10% Owner of Rapt Therapeutics, Inc.. (stock ticker symbol RAPT).
Also see all insider trading activities at Rapt Therapeutics, Inc..
Insider Buying | Insider Sales | Option Exercises | |||||
---|---|---|---|---|---|---|---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
2022 | RAPT | 1,250,000 | $13,340,000 | 0 | $0 | 0 | $0 |
2021 | RAPT | 0 | $0 | 391,101 | $13,699,874 | 9,239 | $214,871 |
Insider Buying | Insider Sales | Option Exercises | |||||
---|---|---|---|---|---|---|---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
2021 | ORIC | 0 | $0 | 0 | $0 | 16,625 | $266,000 |
1. Rapt Therapeutics, Inc. (RAPT)
2. Oric Pharmaceuticals, Inc. (ORIC)
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|---|---|---|---|---|
2022-05-10 | RAPT | Buy | 1,250,000 | 10.67 | 13,340,000 |
2021-09-27 | RAPT | Option Ex | 9,239 | 23.26 | 214,871 |
2021-09-27 | RAPT | Sale | 9,239 | 34.80 | 321,489 |
2021-09-14 | RAPT | Sale | 147,676 | 36.63 | 5,409,371 |
2021-09-15 | RAPT | Sale | 33,535 | 37.45 | 1,255,986 |
2021-09-10 | RAPT | Sale | 21,738 | 35.19 | 765,003 |
2021-09-13 | RAPT | Sale | 14,317 | 35.27 | 504,946 |
2021-09-01 | RAPT | Sale | 31,749 | 35.23 | 1,118,549 |
2021-09-02 | RAPT | Sale | 37,101 | 35.43 | 1,314,562 |
2021-08-20 | RAPT | Sale | 4,539 | 30.08 | 136,533 |
2021-08-23 | RAPT | Sale | 68,340 | 31.57 | 2,157,630 |
2021-08-24 | RAPT | Sale | 22,867 | 31.30 | 715,805 |
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|---|---|---|---|---|
2021-11-12 | ORIC | Option Ex | 16,625 | 16.00 | 266,000 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Column Group Llc (10% Owner of Rapt Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.